<i>GPX3</i> Variant Genotype Affects the Risk of Developing Severe Forms of COVID-19.

导出 OA

翻译打印收藏纠错

作者： Marko,Markovic ^[1] ; Jovan,Ranin ^[2] ; Zoran,Bukumiric ^[1] ; Djurdja,Jerotic ^[2] ; Ana,Savic-Radojevic ^[2] ; Marija,Pljesa-Ercegovac ^[3] ; Tatjana,Djukic ^[2] ; Marko,Ercegovac ^[4] ; Milika,Asanin ^[5] ; Ivana,Milosevic ^[2] ; Goran,Stevanovic ^[4] ; Tatjana,Simic ^[5] ; Vesna,Coric ^[2] ; Marija,Matic ^[4]

作者单位： Clinic of Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia. ^[1] Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia. ^[2] Institute of Medical Statistics and Informatics, 11000 Belgrade, Serbia. ^[3] Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia. ^[4] Centre for Excellence for Redox Medicine, Pasterova 2, 11000 Belgrade, Serbia. ^[5] Clinic of Neurology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia. ^[6] Clinic of Cardiology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia. ^[7] Department of Medical Sciences, Serbian Academy of Sciences and Arts, 11000 Belgrade, Serbia. ^[8]

关键词 COVID-19 GPX3 antioxidant genetic profile disease progression inflammatory markers oxidative stress

主题词人类(Humans);基因型(Genotype);多态现象, 遗传(Polymorphism, Genetic);纤维蛋白原(Fibrinogen);谷胱甘肽过氧化酶(Glutathione Peroxidase);谷胱甘肽转移酶(Glutathione Transferase)

DOI 10.3390/ijms242216151

PMID 38003341

发布时间 2023-11-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交